General MedicationsORALStandard
GLIPIZIDE
GLIPIZIDE
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview GLIPIZIDE is listed in Drugs@FDA under application 206928 (ANDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient GLIPIZIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2023-03-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview GLIPIZIDE is listed in Drugs@FDA under application 206928 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient GLIPIZIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2023-03-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.